3 of the healthcare products unveiled at CES 2016

The Consumer Electronics Show kicked off this week and the first few announcements indicate some exciting innovations.

Samsung Electronics unveiled an advanced system logic chip for consumer-facing wearables. The Bio-Processor is designed to measure body fat, heart rate, heart rhythm, skin temperature, stress level and skeletal muscle mass without the need for external processing parts.

The tiny processor is about one-fourth the size of previous chips and will be displayed at the show in Las Vegas in a variety of wearables, including wristbands, strap-n devices and patches.

Blood pressure monitor market leader, Omron Healthcare, will display two new devices and previewed an initiative to evolve the blood pressure category to "do more to improve heart health for millions of hypertensive individuals."

Omron’s "Project Zero" Wrist and Upper Arm Blood Pressure Monitors and the new OMRON Connect App are clinically-tested, highly accurate heart health tools that will be available this year, according to the company.

Withings has extended its therapeutic areas of expertise with the unveiling of Withings Thermo--a Wi-Fi-connected temporal artery thermometer with a 16-sensor array for a fast, accurate, non-invasive temperature reading.

Withings Thermo measures the temperature from the temporal artery at the side of head with HotSpot Sensor Technology: a sophisticated sensor array of 16 independent infrared sensors that can quickly locate and measure the IR signature and heat being emitted.

With just a point in the direction of the artery, without requiring any motion or scanning, the sensors take 4,000 measurements in 2 seconds while a specially-designed algorithm automatically corrects for biases, such as skin heat loss and the ambient temperature. The hottest point is then determined to ensure the most accurate and reliable single temperature reading.

Stay tuned for more news from the show.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.